Invention Grant
US09238649B2 Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
有权
盐酸盐和4-（4 - {[2-（4-氯苯基）-4,4-二甲基环己-1-烯-1-基]甲基哌嗪-1-基）-N - （{3-硝基 - 4 - [（四氢-2H-吡喃-4-基甲基）氨基]苯基}磺酰基）-2-（1H-吡咯并[2,3-b]吡啶-5-基氧基）苯甲酰胺
![Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide](/docs/US/2016-01-19/US09238649B2/abs.jpg.600x600.jpg)
- Patent Title: Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
- Patent Title (中): 盐酸盐和4-（4 - {[2-（4-氯苯基）-4,4-二甲基环己-1-烯-1-基]甲基哌嗪-1-基）-N - （{3-硝基 - 4 - [（四氢-2H-吡喃-4-基甲基）氨基]苯基}磺酰基）-2-（1H-吡咯并[2,3-b]吡啶-5-基氧基）苯甲酰胺
-
Application No.: US14228132Application Date: 2014-03-27
-
Publication No.: US09238649B2Publication Date: 2016-01-19
- Inventor: Nathaniel Catron , Shuang Chen , Yuchuan Gong , Geoff G. Zhang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/397 ; A61K31/497 ; C07D471/04
![Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide](/abs-image/US/2016/01/19/US09238649B2/abs.jpg.150x150.jpg)
Abstract:
Salts and crystalline forms of 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}-sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide are suitable active pharmaceutical ingredients for pharmaceutical compositions useful in treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.
Public/Granted literature
- US20140213596A1 SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT Public/Granted day:2014-07-31
Information query
IPC分类:
